Tisagenlecleucel Intravenous and Hepatitis B reactivation
Result of checking the interaction of drug Tisagenlecleucel Intravenous and disease Hepatitis B reactivation for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:The use of drugs directed against B cells, such as axicabtagene ciloleucel, and tisagenlecleucel is associated with hepatitis B reactivation, some cases have resulted in fulminant hepatitis, hepatic failure, and death. Close monitoring is recommended when using these agents in patients with a history of hepatitis infection. It is recommended to screen patients for HBV, HCV, and HIV in accordance with clinical guidelines before collection of cells for manufacturing.
Generic Name: tisagenlecleucel
Brand Name: Kymriah
Synonyms: Tisagenlecleucel
Tisagenlecleucel Intravenous - reaktywacja zapalenia wątroby typu B. 
Tisagenlecleucel Intravenous - reativação da hepatite B 
Tisagenlecleucel Intravenous - pengaktifan semula hepatitis B 
Tisagenlecleucel Intravenous - pengaktifan kembali hepatitis B. 
Tisagenlecleucel Intravenous - riattivazione dell'epatite B. 
Tisagenlecleucel Intravenous - réactivation de l'hépatite B 
Tisagenlecleucel Intravenous - Hepatitis B-Reaktivierung 
Tisagenlecleucel Intravenous - reactivación de la hepatitis B 
Tisagenlecleucel Intravenous - реактивация гепатита В 
Tisagenlecleucel Intravenous - hepatit B reaktivasyonu 
Tisagenlecleucel Intravenous - إعادة تنشيط التهاب الكبد ب 
Tisagenlecleucel Intravenous - 乙肝活化